A double-blind, placebo-controlled, phase-II clinical trial to evaluate oral simvastatin as a treatment for vitiligo

J Am Acad Dermatol. 2017 Jan;76(1):150-151.e3. doi: 10.1016/j.jaad.2016.06.015.
No abstract available

Publication types

  • Clinical Trial, Phase II
  • Letter
  • Randomized Controlled Trial

MeSH terms

  • Administration, Oral
  • Adolescent
  • Adult
  • Body Surface Area
  • Chemokine CXCL10 / blood
  • Double-Blind Method
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / administration & dosage*
  • Male
  • Middle Aged
  • Severity of Illness Index
  • Simvastatin / administration & dosage*
  • Treatment Outcome
  • Vitiligo / blood
  • Vitiligo / drug therapy*
  • Young Adult

Substances

  • CXCL10 protein, human
  • Chemokine CXCL10
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Simvastatin